BECTON, DICKINSON AND COMPANY Payments for (Proceeds from) Investments
BECTON, DICKINSON AND COMPANY (BDX) reported Payments for (Proceeds from) Investments of -$27.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY payments for (proceeds from) investments for the quarter ending 2026-06-30 was -$4.00M, a 180.00% decline year-over-year.
- BECTON, DICKINSON AND COMPANY payments for (proceeds from) investments for the quarter ending 2026-03-31 was -$23.00M.
- BECTON, DICKINSON AND COMPANY payments for (proceeds from) investments for the quarter ending 2025-12-31 was $0.00.
- BECTON, DICKINSON AND COMPANY payments for (proceeds from) investments for the quarter ending 2025-09-30 was -$14.00M.
- BECTON, DICKINSON AND COMPANY payments for (proceeds from) investments for fiscal 2025 was -$422.00M, a 200.24% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY payments for (proceeds from) investments for fiscal 2024 was $421.00M.
- BECTON, DICKINSON AND COMPANY payments for (proceeds from) investments for fiscal 2023 was $0.00.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 6 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | -$27.00M derived: sum of 2 quarters · filed 2026-08-06 | -$27.00M 10-Q · filed 2026-08-06 | -$41.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | -$23.00M 10-Q · filed 2026-05-07 | -$37.00M derived: sum of 3 quarters · filed 2026-05-07 | -$32.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-09 | -$14.00M derived: sum of 2 quarters · filed 2026-02-09 | -$9.00M derived: sum of 3 quarters · filed 2026-08-06 | -$11.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | -$14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$9.00M derived: sum of 2 quarters · filed 2026-08-06 | -$11.00M derived: sum of 3 quarters · filed 2026-08-06 | -$422.00M 10-K · filed 2025-11-25 |
| 2025-06-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $3.00M derived: sum of 2 quarters · filed 2026-08-06 | -$408.00M 10-Q · filed 2026-08-06 | -$817.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | -$413.00M 10-Q · filed 2026-05-07 | -$822.00M derived: sum of 3 quarters · filed 2026-05-07 | -$807.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$411.00M 10-Q · filed 2026-02-09 | -$820.00M derived: sum of 2 quarters · filed 2026-02-09 | -$805.00M derived: sum of 3 quarters · filed 2026-02-09 | |
| 2024-09-30 | -$409.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$394.00M derived: sum of 2 quarters · filed 2025-11-25 | $421.00M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $830.00M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $815.00M 10-Q · filed 2025-05-01 | |||
| 2023-09-30 | $0.00 10-K · filed 2025-11-25 | |||
| 2013-06-30 | -$41.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-05 | -$242.37M derived: sum of 2 quarters · filed 2013-08-05 | -$156.75M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | -$201.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | -$115.71M 10-Q · filed 2013-05-09 | ||
| 2012-12-31 | $85.63M 10-Q · filed 2013-02-07 | |||
| 2012-06-30 | $280.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-05 | $48.09M derived: sum of 2 quarters · filed 2013-08-05 | $158.07M 10-Q · filed 2013-08-05 | |
| 2012-03-31 | -$232.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | -$122.27M 10-Q · filed 2013-05-09 | ||
| 2011-12-31 | $109.98M 10-Q · filed 2013-02-07 | |||
| 2011-06-30 | -$361.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-06 | -$259.03M derived: sum of 2 quarters · filed 2012-08-06 | $204.98M 10-Q · filed 2012-08-06 | |
| 2011-03-31 | $102.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-03 | $566.69M 10-Q · filed 2012-05-03 | ||
| 2010-12-31 | $464.01M 10-Q · filed 2012-02-07 | |||
| 2010-06-30 | $270.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-08-02 | $426.47M derived: sum of 2 quarters · filed 2011-08-02 | $146.88M 10-Q · filed 2011-08-02 | |
| 2010-03-31 | $155.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-05-04 | -$123.63M 10-Q · filed 2011-05-04 | ||
| 2009-12-31 | -$279.59M 10-Q · filed 2011-02-08 | |||
| 2009-06-30 | $206.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-08-04 | $214.24M derived: sum of 2 quarters · filed 2010-08-04 | $223.06M 10-Q · filed 2010-08-04 | |
| 2009-03-31 | $7.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-05-06 | $16.23M 10-Q · filed 2010-05-06 | ||
| 2008-12-31 | $8.82M 10-Q · filed 2010-02-08 | |||
| 2008-06-30 | $50.17M 10-Q · filed 2009-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |